S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

Inovalon Stock Forecast, Price & News

+0.07 (+0.17%)
(As of 11/23/2021)
Today's Range
50-Day Range
52-Week Range
3.37 million shs
Average Volume
720,587 shs
Market Capitalization
$6.37 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive INOV News and Ratings via Email

Sign-up to receive the latest news and ratings for Inovalon and its competitors with MarketBeat's FREE daily newsletter.

Inovalon logo

About Inovalon

Inovalon Holdings, Inc. engages in the development of cloud-based platforms for the healthcare industry. Its products include datasets, integration technologies, predictive analytics, and related services. The company was founded in 1998 and is headquartered in Bowie, MD.


Inovalon (NASDAQ:INOV) Reaches New 12-Month High at $41.06
November 24, 2021 |  americanbankingnews.com
Inovalon (NASDAQ:INOV) Sees Large Volume Increase
November 22, 2021 |  americanbankingnews.com
Inovalon Holdings, Inc. (NASDAQ:INOV) Short Interest Update
November 21, 2021 |  americanbankingnews.com
Inovalon (NASDAQ:INOV) Reaches New 1-Year High at $41.00
November 18, 2021 |  americanbankingnews.com
Head-To-Head Survey: Clarivate (NYSE:CLVT) and Inovalon (NASDAQ:INOV)
November 17, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Data processing & preparation
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$667.52 million
Cash Flow
$1.23 per share
Book Value
$4.94 per share


Net Income
$22.58 million
Pretax Margin




Free Float
Market Cap
$6.37 billion

Company Calendar

Last Earnings
Fiscal Year End
Next Earnings (Estimated)


Overall MarketRank

1.65 out of 5 stars

Computer And Technology Sector

624th out of 891 stocks

Data Processing & Preparation Industry

63rd out of 99 stocks

Analyst Opinion: 1.1Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -

Inovalon (NASDAQ:INOV) Frequently Asked Questions

Is Inovalon a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Inovalon in the last year. There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Inovalon stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INOV, but not buy additional shares or sell existing shares.
View analyst ratings for Inovalon
or view top-rated stocks.

How has Inovalon's stock price been impacted by Coronavirus (COVID-19)?

Inovalon's stock was trading at $17.36 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, INOV stock has increased by 136.5% and is now trading at $41.06.
View which stocks have been most impacted by COVID-19

Are investors shorting Inovalon?

Inovalon saw a decline in short interest in October. As of October 29th, there was short interest totaling 4,500,000 shares, a decline of 19.2% from the October 14th total of 5,570,000 shares. Based on an average trading volume of 1,110,000 shares, the days-to-cover ratio is presently 4.1 days. Currently, 6.1% of the company's stock are sold short.
View Inovalon's Short Interest

When is Inovalon's next earnings date?

Inovalon is scheduled to release its next quarterly earnings announcement on Wednesday, February 2nd 2022.
View our earnings forecast for Inovalon

How were Inovalon's earnings last quarter?

Inovalon Holdings, Inc. (NASDAQ:INOV) announced its earnings results on Wednesday, July, 28th. The technology company reported $0.19 EPS for the quarter, topping analysts' consensus estimates of $0.17 by $0.02. The technology company earned $190.44 million during the quarter, compared to analysts' expectations of $183.89 million. Inovalon had a trailing twelve-month return on equity of 10.97% and a net margin of 6.73%.
View Inovalon's earnings history

What price target have analysts set for INOV?

6 Wall Street analysts have issued 1 year price objectives for Inovalon's stock. Their forecasts range from $23.00 to $41.00. On average, they anticipate Inovalon's stock price to reach $32.67 in the next year. This suggests that the stock has a possible downside of 20.4%.
View analysts' price targets for Inovalon
or view top-rated stocks among Wall Street analysts.

Who are Inovalon's key executives?

Inovalon's management team includes the following people:
  • Keith R. Dunleavy, Chairman & Chief Executive Officer
  • Eron S. Kelly, President
  • Jonathan R. Boldt, Chief Financial & Accounting Officer
  • Paige C. Kilian, Chief Medical Officer
  • Monica Keeneth, Chief Information Security Officer & VP

What is Keith R. Dunleavy's approval rating as Inovalon's CEO?

410 employees have rated Inovalon CEO Keith R. Dunleavy on Glassdoor.com. Keith R. Dunleavy has an approval rating of 57% among Inovalon's employees. This puts Keith R. Dunleavy in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Inovalon own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inovalon investors own include Advanced Micro Devices (AMD), Pfizer (PFE), Alibaba Group (BABA), DexCom (DXCM), NVIDIA (NVDA), Digital Turbine (APPS), PayPal (PYPL), Square (SQ), Taiwan Semiconductor Manufacturing (TSM) and Enphase Energy (ENPH).

When did Inovalon IPO?

(INOV) raised $500 million in an IPO on Thursday, February 12th 2015. The company issued 22,200,000 shares at $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank served as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers.

What is Inovalon's stock symbol?

Inovalon trades on the NASDAQ under the ticker symbol "INOV."

Who are Inovalon's major shareholders?

Inovalon's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (3.28%), Millennium Management LLC (2.05%), ArrowMark Colorado Holdings LLC (1.98%), Citigroup Inc. (1.30%), Morgan Stanley (1.11%) and Neuberger Berman Group LLC (1.00%). Company insiders that own Inovalon stock include Bock Peter De, Jason Capitel, Jonathan R Boldt, Keith R Dunleavy, Mark Pulido, Robert A Wychulis and William J Teuber Jr.
View institutional ownership trends for Inovalon

Which institutional investors are selling Inovalon stock?

INOV stock was sold by a variety of institutional investors in the last quarter, including Eaton Vance Management, Invesco Ltd., BlackRock Inc., Neuberger Berman Group LLC, Cowen Prime Advisors LLC, RE Advisers Corp, King Luther Capital Management Corp, and ArrowMark Colorado Holdings LLC. Company insiders that have sold Inovalon company stock in the last year include Jason Capitel, Jonathan R Boldt, and Mark Pulido.
View insider buying and selling activity for Inovalon
or view top insider-selling stocks.

Which institutional investors are buying Inovalon stock?

INOV stock was acquired by a variety of institutional investors in the last quarter, including Millennium Management LLC, Citigroup Inc., Morgan Stanley, Alpine Associates Management Inc., TIG Advisors LLC, UBS Group AG, Balyasny Asset Management LLC, and CNH Partners LLC. Company insiders that have bought Inovalon stock in the last two years include Bock Peter De, Keith R Dunleavy, and William J Teuber Jr.
View insider buying and selling activity for Inovalon
or or view top insider-buying stocks.

How do I buy shares of Inovalon?

Shares of INOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Inovalon's stock price today?

One share of INOV stock can currently be purchased for approximately $41.06.

How much money does Inovalon make?

Inovalon has a market capitalization of $6.37 billion and generates $667.52 million in revenue each year. The technology company earns $22.58 million in net income (profit) each year or $0.34 on an earnings per share basis.

How many employees does Inovalon have?

Inovalon employs 1,836 workers across the globe.

What is Inovalon's official website?

The official website for Inovalon is www.inovalon.com.

Where are Inovalon's headquarters?

Inovalon is headquartered at 4321 COLLINGTON ROAD, BOWIE MD, 20716.

How can I contact Inovalon?

Inovalon's mailing address is 4321 COLLINGTON ROAD, BOWIE MD, 20716. The technology company can be reached via phone at (301) 809-4000, via email at [email protected], or via fax at 301-809-8060.

This page was last updated on 11/29/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.